Shin J, Park H, Kim H, et al
However, the therapeutic effects of GHK-Cu on UC have not been fully investigated
Zepbound (tirzepatide) is an FDA-approved prescription medication indicated for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition, such as hypertension, type 2 diabetes, or dyslipidemia
There are not a lot of long-term data: Additional studies are necessary to ensure the safety of long-term use
Symptoms of a significant allergic reaction might include: Hives Extensive rash Swelling of the face, mouth, or throat Should an individual exhibit signs of anaphylaxis , a serious and potentially life-threatening condition, immediate medical attention is necessary